Prevalence, risk factors and survival of lung cancer in the idiopathic pulmonary fibrosis

Thoracic Cancer

Volumn 3, Issue 2, 2012, Pages 150-155

  Lee, Kyung Jong ^a   Chung, Man Pyo ^a   Kim, Young Whan ^b   Lee, Jae Ho ^b   Kim, Kyu Sik ^c   Ryu, Jeong Seon ^d   Lee, Hong Lyeol ^d   Park, Sung Woo ^e   Park, Choon Sik ^e   Uh, Soo Tak ^e   Lee, Yong Chul ^f   Park, Seoung Ju ^f   Kim, Kwan Hyoung ^g   Jeon, Young June ^h   Choi, Won Il ^h   Park, Yong Bum ⁱ   Kim, Dong Soon ^j   Jeong, Sung Hwan ^k   Lee, Jin Hwa ^l   Park, Moo Suk ^m  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Chonnam National University Medical School   (South Korea)

^d Inha University School of Medicine   (South Korea)

^e Soonchunhyang University College of Medicine   (South Korea)

^f Chonbuk National University Medical School   (South Korea)

^g The Catholic University of Korea College of Medicine   (South Korea)

^h Keimyung University   (South Korea)

ⁱ Hallym University College of Medicine   (South Korea)

^j University of Ulsan   (South Korea)

^k Gachon University   (South Korea)

^l Ewha Womans University School of Medicine   (South Korea)

^m Yonsei University College of Medicine   (South Korea)

more..

Author keywords

Idiopathic pulmonary fibrosis; Lung cancer; Prevalence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 84868116251     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/j.1759-7714.2011.00107.x     Document Type: Article

References (17)

1. Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit CareMed 1994; 150: 967-72.
2. Meyer EC, Liebow AA. Relationship of interstitial pneumonia, honeycombing and atypical epithelial proliferation to cancer of the lung. Cancer 1965; 18: 322-51.
3. Hubbard R,Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis: a population-based cohort study. Am J Respir Crit CareMed 2000; 161: 5-8.
4. Le Jeune I,Gribbin J,West J, Smith C, Cullinan P,Hubbard R. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. RespirMed 2007; 101: 2534-40.
5. Matsushita H, Tanaka S, Saiki Yet al. Lung cancer associated with usual interstitial pneumonia. Pathol Int 1995; 45: 925-32.
6. Turner-Warwick M, Lebowitz M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980; 35: 496-9.
7. Aubry MC,Myers JL, Douglas WW et al. Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis. Mayo Clin Proc 2002; 77: 763-70.
8. American Thoracic Society (ATS)/European Respiratory Society (ERS). American Thoracic Society/European Respiratory Society InternationalMultidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit CareMed 2002; 165: 277-304.
9. Hironaka M, Fukayama M. Pulmonary fibrosis and lung carcinoma: a comparative study of metaplastic epithelia in honeycombed areas of usual interstitial pneumonia with or without lung carcinoma. Pathol Int 1999; 49: 1060-6.
10. Harris JM, Cullinan P, McDonald JC. Does cryptogenic fibrosing alveolitis carry an increased risk of death from lung cancer?J Epidemiol Community Health 1998; 52: 602-3.
11. Wells C,Mannino DM. Pulmonary fibrosis and lung cancer in the United States: analysis of themultiple cause of death mortality data, 1979 through 1991. SouthMed J 1996; 89: 505-10.
12. Ozawa Y, Suda T, Naito T et al. Cumulative incidence of and predictive factors for lung cancer in IPF. Respirology 2009; 14: 723-8.
13. Nagai A, Chiyotani A, Nakadate T, Konno K. Lung cancer in patients with idiopathic pulmonary fibrosis. Tohoku J Exp Med 1992; 167: 231-7.
14. Mizushima Y, Kobayashi M. Clinical characteristics of synchronousmultiple lung cancer associated with idiopathic pulmonary fibrosis.A review of Japanese cases. Chest 1995; 108: 1272-7.
15. Vassilakis DA, Sourvinos G, Spandidos DA, Siafaks NM, Bouros D. Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis. Am J Respir Crit CareMed 2000; 162: 1115-9.
16. Zappala CJ, Latsi PI, Nicholson AG et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur Respir J 2010; 35: 830-6.
17. Korean Central Cancer RegistryMoHaW. Annual Report of the Korean Central Cancer Registry.Ministry of Health and Welfare, Goyang 2005.